Literature DB >> 20484026

Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma.

Linda Hanlon1, Jacqueline L Avila, Renée M Demarest, Scott Troutman, Megan Allen, Francesca Ratti, Anil K Rustgi, Ben Z Stanger, Fred Radtke, Volkan Adsay, Fenella Long, Anthony J Capobianco, Joseph L Kissil.   

Abstract

K-ras is the most commonly mutated oncogene in pancreatic cancer and its activation in murine models is sufficient to recapitulate the spectrum of lesions seen in human pancreatic ductal adenocarcinoma (PDAC). Recent studies suggest that Notch receptor signaling becomes reactivated in a subset of PDACs, leading to the hypothesis that Notch1 functions as an oncogene in this setting. To determine whether Notch1 is required for K-ras-induced tumorigenesis, we used a mouse model in which an oncogenic allele of K-ras is activated and Notch1 is deleted simultaneously in the pancreas. Unexpectedly, the loss of Notch1 in this model resulted in increased tumor incidence and progression, implying that Notch1 can function as a tumor suppressor gene in PDAC. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484026      PMCID: PMC2880196          DOI: 10.1158/0008-5472.CAN-09-4645

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  The love-hate relationship between Ras and Notch.

Authors:  Meera V Sundaram
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

2.  Deficient T cell fate specification in mice with an induced inactivation of Notch1.

Authors:  F Radtke; A Wilson; G Stark; M Bauer; J van Meerwijk; H R MacDonald; M Aguet
Journal:  Immunity       Date:  1999-05       Impact factor: 31.745

3.  Notch1 functions as a tumor suppressor in mouse skin.

Authors:  Michael Nicolas; Anita Wolfer; Kenneth Raj; J Alain Kummer; Pleasantine Mill; Mascha van Noort; Chi-chung Hui; Hans Clevers; G Paolo Dotto; Freddy Radtke
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

Review 4.  The Notch pathway in cancer: differentiation gone awry.

Authors:  Jonas Sjölund; Christina Manetopoulos; Marie-Thérése Stockhausen; Håkan Axelson
Journal:  Eur J Cancer       Date:  2005-10-18       Impact factor: 9.162

5.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.

Authors:  Yoshiharu Miyamoto; Anirban Maitra; Bidyut Ghosh; Ulrich Zechner; Pedram Argani; Christine A Iacobuzio-Donahue; Virote Sriuranpong; Tatsuya Iso; Ingrid M Meszoely; Michael S Wolfe; Ralph H Hruban; Douglas W Ball; Roland M Schmid; Steven D Leach
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

6.  Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium.

Authors:  Hippokratis Kiaris; Katerina Politi; Lisa M Grimm; Matthias Szabolcs; Peter Fisher; Argiris Efstratiadis; Spyros Artavanis-Tsakonas
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

7.  Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene.

Authors:  Franz S Schreiber; Therese B Deramaudt; Thomas B Brunner; Michael I Boretti; Keith J Gooch; Doris A Stoffers; Eric J Bernhard; Anil K Rustgi
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

8.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

9.  Notch signaling is required for exocrine regeneration after acute pancreatitis.

Authors:  Jens T Siveke; Clara Lubeseder-Martellato; Marcel Lee; Pawel K Mazur; Hassan Nakhai; Freddy Radtke; Roland M Schmid
Journal:  Gastroenterology       Date:  2007-11-04       Impact factor: 22.682

10.  Common activation of canonical Wnt signaling in pancreatic adenocarcinoma.

Authors:  Marina Pasca di Magliano; Andrew V Biankin; Patrick W Heiser; David A Cano; Pedro J A Gutierrez; Therese Deramaudt; Davendra Segara; Amanda C Dawson; James G Kench; Susan M Henshall; Robert L Sutherland; Andrzej Dlugosz; Anil K Rustgi; Matthias Hebrok
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more
  67 in total

Review 1.  Novel therapeutic targets for pancreatic cancer.

Authors:  Shing-Chun Tang; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

Authors:  Adrienne D Cox; Channing J Der; Mark R Philips
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

3.  Notch Signaling Pathway in Pancreatic Cancer Progression.

Authors:  Jia Ma; Jun Xia; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Pancreat Disord Ther       Date:  2013-05-30

4.  Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.

Authors:  S Zhang; W-C Chung; K Xu
Journal:  Oncogene       Date:  2015-08-17       Impact factor: 9.867

Review 5.  Cells of origin of pancreatic neoplasms.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Masato Nagino
Journal:  Surg Today       Date:  2017-03-04       Impact factor: 2.549

6.  Cellular Prion Protein Mediates Pancreatic Cancer Cell Survival and Invasion through Association with and Enhanced Signaling of Notch1.

Authors:  Yiwei Wang; Shuiliang Yu; Dan Huang; Min Cui; Huankai Hu; Lihua Zhang; Weihuan Wang; Neetha Parameswaran; Mark Jackson; Barbara Osborne; Barbara Bedogni; Chaoyang Li; Man-Sun Sy; Wei Xin; Lan Zhou
Journal:  Am J Pathol       Date:  2016-09-14       Impact factor: 4.307

Review 7.  Deploying mouse models of pancreatic cancer for chemoprevention studies.

Authors:  Paul J Grippo; David A Tuveson
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-02

Review 8.  Notch as a tumour suppressor.

Authors:  Craig S Nowell; Freddy Radtke
Journal:  Nat Rev Cancer       Date:  2017-02-03       Impact factor: 60.716

9.  Cancer: The flipside of Notch.

Authors:  Demetrios Kalaitzidis; Scott A Armstrong
Journal:  Nature       Date:  2011-05-12       Impact factor: 49.962

10.  Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.

Authors:  Helen Court; Marc Amoyel; Michael Hackman; Kyoung Eun Lee; Ruliang Xu; George Miller; Dafna Bar-Sagi; Erika A Bach; Martin O Bergö; Mark R Philips
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.